Cargando…
Tolerance to rat monoclonal antibodies. Implications for serotherapy
The antiglobulin response is a major complication of mAb therapy. It has been suggested that, in clinical practice, this might be avoided by using human or chimeric mAbs, or by prior induction of tolerance to the therapeutic mAb. In this study, we show that it is possible to induce tolerance in mice...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1986
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2188130/ https://www.ncbi.nlm.nih.gov/pubmed/3486938 |
Ejemplares similares
-
Serotherapy of L1210 murine leukaemia--reasons for ineffectiveness of in vivo treatment by L.1 monoclonal antibody.
por: Testorelli, C., et al.
Publicado: (1983) -
110 Broadly neutralizing antibodies for serotherapy and vaccine design
por: Lanzavecchia, Antonio
Publicado: (2014) -
Potential and challenges of serotherapy for severe influenza
por: Lee, Nelson, et al.
Publicado: (2017) -
Serotherapy of a spontaneous mouse tumour.
por: O'Neill, G. J.
Publicado: (1980) -
Paths to the discovery of antivenom serotherapy in France
por: Bochner, Rosany
Publicado: (2016)